(Surg2) 5.1a Introduction To Anesthesia Part 1
(Surg2) 5.1a Introduction To Anesthesia Part 1
(Surg2) 5.1a Introduction To Anesthesia Part 1
those with morbid obesity with a BMI of more than 40, active without COPD, mild obesity, and
hepatitis, alcohol dependence or abuse, those with implanted pregnancy.
pacemaker and moderate reduction of ejection fraction, those • Some functional limitations
with end stage renal disease undergoing regularly scheduled • Has a controlled disease of
dialysis, premature infant, bronchospastic lung disease with more than one body system or
intermittent exacerbation and stable angina. The absolute one major system.
mortality rate for this group is about 1.8 to 4.5% and the 30-day • NO immediate danger of death
death probability is about 5-10 %. • Controlled CHF, stable angina,
IV A patient with severe systemic disease that is a old heart attack, poorly
constant threat to life. controlled HTN, morbid obesity
In Class 4, are those with incapacitating illness that is a ASA PS A patient with
BMI of at least 40, end-stage
constant threat to life so under these we have patients with 3 severe disease
renal disease with regularly
functional limitation, such as unstable angina, poorly controlled schedule dialysis,
COPD, symptomatic congestive heart failure, recent bronchospastic disease with
myocardial infarction, or stroke, also those with dyspnea and intermittent exacerbation, active
patients with end stage renal disease not undergoing regularly alcohol dependence or abuse,
scheduled dialysis. The absolute mortality rate is 7.8 to 25.9% implanted pacemakers,
and the 30-day death probability is more than 10%. moderate reduction of ejection
V A moribund patient who is not expected to survive fraction, premature infant
without the operation • Has at least one severe
In Class 5, patients are not expected to live for more than disease that is poorly controlled
24 hours, such as those with ruptured thoracic aneurysm, or at end stage.
massive trauma, intracranial bleed with mass effect, ischemic A patient with
• Possible risk of death
bowel, significant cardiac pathology, multiple organ system severe systemic
ASA PS • Unstable angina, symptomatic
dysfunction and hypovolemic patients. The absolute mortality disease that is a
4 poorly controlled COPD,
rate is 9.4 to 57.8%. constant threat
symptomatic CHF, hepatorenal
VI A declared brain dead patient whose organs are being to life
failure without regular dialysis,
removed for donor purposes.
recent myocardial infarction or
In Class 5, are those with declared brain-dead patients for
stroke, dyspnea
organ donor. So, a brain-dead patient whose organs are being
• Not expected to survive
removed with the intention of transplanting them into another
>24hours without surgery.
patient.
• Imminent risk of death
We append an “E” if the patient comes in as an emergency.
• Multi-organ failure, sepsis
Capital Letter E denotes an Emergency Surgical Procedure.
A moribund syndrome with hemodynamic
An emergency is defined as existing when delay in treatment
patient who is instability, hypothermia, poorly
of the patient would lead to a significant increase in threat to ASA PS
not expected to controlled coagulopathy,
life. 5
survive without ruptured thoracic or abdominal
PLEASE STUDY THIS TABLE. 😊
the operation aneurysm, massive trauma,
DOC SAID “THIS IS ANOTHER TABLE SHOWING THE ASA intracranial bleed with mass
PHYSICAL STATUS CLASSIFICATION. I WANT YOU TO effect, ischemic bowel with
FOCUS ON THE COMMENTS AND EXAMPLES” PLEASE insignificant cardiac pathology,
STUDY THIS TABLE!! hypovolemic patient.
Table 2. ASA Physical Status (PS) Classified System A declared
brain-dead —
Perioperative Comments, Examples
Category ASA PS patient whose
Health Status
6 organs are being
• NO organic, physiologic, or
removed for
psychiatric disturbance
donor purposes
ASA PS Normal healthy • Excludes the very young and
C. OBJECTIVES – PREOPERATIVE MEDICATION
1 patient very old.
• Reduce anxiety and fear.
• Healthy with good exercise
• Promote relaxation.
tolerance
• Reduce pharyngeal secretions.
• No functional limitations
o Especially for smoker patients
• Has a well-controlled disease
A patient with • Prevent laryngospasm.
ASA PS of one body system.
mild systemic o Pediatric patients because they are prone to this.
2 • Controlled hypertension or
disease • Reduce the volume and increase the pH of gastric secretions.
diabetes without systemic
o Reason why patients scheduled for elective surgery are
effects, cigarette smoking
advised to do fasting.
• Decrease the amount of anesthetic needed.
SEQUENCE OF LA
Figure 1: Components of LA
The sequence of Anesthesia relates to the nerve fiber
Local Anesthetics Molecules consists of 3 three components, biology.
each of which contribute distinct properties of the molecule. • SMALL DIAMETER FIBERS ARE MORE SENSITIVE to LAs
I. Aromatic ring than larger diameter fibers.
► Determines the lipid solubility, hence, the POTENCY The distance of impulse propagation in small fibers is
II. Intermediate chain shorter.
► Either an ester or amides linkage • MYELINATED FIBERS ARE MORE SENSITIVE than
► Determines the pattern of biotransformation or their unmyelinated fibers.
potential stability in the solution Since myelinated nerves need only to be block at several
III. Amine group nodes of Ranvier to inhibit the impulse propagation thus
► Either in tertiary form/insoluble form OR requiring smaller concentration of anesthetics.
quaternary/water soluble form • Nerves with HIGHER FIRING FREQUENCY ARE MORE
► Dependent on the pH SENSITIVE
► Determines the time of onset • The affinity of LAs for Na+ channels DEPENDS ON THE
• Amphiphilic (Water-loving and fat-loving) property STATE OF CHANNEL
MECHANISM OF ACTION OF LA o Open state → Inactivated state → Resting state.
• Reduce the entry of Na+ (Fast voltage gated channels) Meaning the Open State has a greater affinity, followed by
• Initiation and propagation of nerve impulse the inactivated state then the resting state
• At higher doses, it also blocks: • PAIN FIBERS HAVE HIGHER FIRING RATE and relatively
o Voltage-gated Ca++ channels LONGER ACTION POTENTIAL than motor fibers and thus
are MORE SENSITIVE
Table 3. Sequence of LA Block
Diffusion of base through nerve sheath
↓
Binding of cationic form to membrane receptor site
↓
Blockade to sodium channel
• Used for infiltration anesthesia, o Manifests first in the more sensitive CNS and then the
IV block or IV regional cardiovascular system.
anesthesia, peripheral and
regional blocks, and topical CENTRAL NERVOUS SYSTEM EFFECTS OF LA
anesthesia for the skin and • EARLY
extremities o Lightheadedness, perioral/tongue numbness, metallic
• Classified as Class 1B anti- taste
arrythmic • IN HIGHER DOSE
• Used for the treatment of o Tinnitus, visual dysfunction, agitation, anxiety
ventricular • IN A MUCH HIGHER DOSE
arrhythmia/tachycardia o CNS depression, unconsciousness, respiratory arrest,
• A/E: Malignant hyperthermia seizure activity
due to accumulation of Calcium ▪ Treatment for LA-induced seizure: Hyperventilation
• Used for regional block as a AND Benzodiazepines or small doses of Thiopental
Etidocaine (Duranest) preference for motor fiber ▪ If the seizure persists, the trachea must be intubated
sensory fibers with a cuffed endotracheal tube to guard against
pulmonary aspiration of stomach contents.
• A sympathomemtic due to
norepinephrine reuptake
CARDIOVASCULAR EFFECTS OF LA
• A vasoconstrictor
• Cardiac arrhythmias, depressed contractility, and cardiac
• Commonly used in the ENT
arrest
surgeries
• Occurs when the blood concentration rises high enough.
• Fast onset of action (about 20-
• LA bind on sodium channels present in myocardial cells that
30 minutes) due to its ability to
Cocaine reduces the myocardial automaticity and shortens the
sensitized adrenergic receptors
refractory period
• Relatively contraindicated to
o With increasingly elevated plasma levels of local
the patient with hypersensitivity
anesthetics, progression to hypotension, increased P-R
and ischemic heart disease
intervals, bradycardia, and cardiac arrest may occur.
• Contraindicated with concurrent
• Greater CARDIOTOXICITY
use with adrenaline because of it
o BUPIVACAINE
is a potent vasoconstrictor
▪ More cardiotoxic than other local anesthetics
• Rapidly metabolized ▪ Has a direct effect on ventricular muscle
Chloroprocaine • Favored by obstetricians because ▪ More lipid soluble than lidocaine, thus it binds tightly to
of its low fetal exposure sodium channels
• Rapid onset and short duration ▪ Experience profound hypotension, ventricular
• NOT effective topically tachycardia and fibrillation, and complete
Procaine
• LA of choice for Malignant atrioventricular heart block that is extremely refractory
Hyperthermia to treatment
• Used as topical and mucosal ▪ Bretylium – DOC for Bupivacaine-induced ventricular
anesthesia by the dentist tachycardia
Benzocaine o ROPIVACAINE
• Associated with
methemoglobinemia
NEUROTOXICITY
• An ester
A. LIDOCAINE 5%
• Has relatively fast onset of
• Cauda Equina Syndrome
action and longer duration
o Permanent neurologic injury
• Effective topically
o Due to spinal microcatheters
• Treat local illness and used to
Tetracaine (Pontocaine, ▪ The pooling of the concentrated local anesthetic in the
desensitize venipuncture site
Amethocaine) catheter fibers cause the neurotoxic effects.
or IV insertion sites, especially
o Discontinued and is replaced by 2% and 4%
for pediatric population
• Transient Neurologic Symptoms (TNS)
• Least metabolized among the
o Transient hypesthesias, paresthesias, and motor
esters
weakness.
• Possess higher risk of toxicity
TNS is significantly more common with Lidocaine
o Usually symptoms resolves for 3 days
SIDE EFFECTS AND TOXICITY OF LAs o But occasionally it persists for as long as six months
• TOXICITY
o Results from absorption into the bloodstream or from B. 2-CHLOROPROCAINE
inadvertent direct intravascular injection. • Due to low pH & metabisulfite preservative
In this picture, field block is done by infiltrating Figure 10: Peripheral Nerve Block
the area surrounding the mass incision or
lacerated wound. ► Nowadays, peripheral nerve block is much safer
because UTZ and nerve stimulator is now being used
VI. PERIPHERAL NERVE BLOCK as a guide
• Peripheral block – means it is applied away from the ► Nerve stimulator gives out microcurrent in
vertebral column. milliampere (mA), which will be detected by the UTZ
• INDICATIONS probe
o High risk of respiratory depression ► There are two wires present:
o To avoid systemic medications ► One is for the electric microcurrent
o Intolerant or not responsive to oral medications ► The other one is for the local anesthetic
► Once the UTZ identified or located a nerve, a needle
• CONTRAINDICATIONS
will be inserted to stimulate the nerve, which will then
o LA allergy
produce a muscle twitch
o Inability to cooperate.
► If there is a muscle twitch, it confirms that it is a nerve
o Patient refusal
► A local anesthetic is then introduced to the other wire
o Infection at the injection site
o Coagulopathy or on antithrombotic drugs
Figure 12: Facial Nerve Block Figure 14: Occipital Nerve Block
Facial Nerve Block is used in Cosmetics Surgery and the Occipital Nerve Block
repair of complex lacerations that might otherwise be
distorted by direct wound infiltration.
Rectus Sheath
• Indications:
o Postoperative analgesia for umbilical hernia repair
and other umbilical surgery
LABAN!
• Complications
VIII. INTRAVENOUS REGIONAL ANESTHESIA (IVRA) o Lidocaine allergy (rare)
Also known as Bier Block and was described by a German o Lidocaine toxicity
surgeon Dr. August Bier in 1908. It is a technique involving o Thrombophlebitis
administration of local anesthetic into a region where venous o Tissue extravasation of anesthetic agent
return is mechanically impeded. So local anesthetic diffuses out • Advantages
to nonvascular tissue such as the axon and nerve ending. So o Easy to administer
the efficacy depends on the interruption of blood flow and the o Low incidence of block failure
probable mechanism of action is the drug action on the nerve o Safe technique when used appropriately
endings and nerve trunks. o Rapid onset and recovery
o Patient is awake during the procedure
o Controllable extent of anesthesia
• Disadvantages
o Only for short procedures
o Tourniquet pain after 20 – 30 minutes
o Sudden cardiovascular collapse or seizures if the
local anesthetic is released into the circulation to
early
Figure 19: Bier Block Procedure Part 4 lifted from PPT Figure 22: Spinal Vertebral Column and Spinal Cord lifted
from PPT enlarged image at the appendix
Next is inflate the proximal cuff 50-100mmHg
above the systolic arterial pressure.
Indications
• Surgeries involving lower half of the body
o Upper abdomen
o Lower abdomen
o Perineum
o Anorectal and lower spine(e.g. Hemorrhoids)
o Lower extremity
• Obstetrics
o Labor analgesia
o Caesarian section
• Painful diagnostic and therapeutic procedures below
Figure 25: The Meninges lifted from PPT the diaphragm
• Postoperative and chronic pain management
The brain and spinal cord are surrounded by three
membranes or meningeal coverings.
Dura mater Contraindications
• The outer covering. • ABSOLUTE
• Envelops the cord loosely. o Patient refusal
• Separated from the arachnoid mater by the
o Infection
subdural space and from the bony wall of the
vertebral canal by the epidural space. o Anticoagulation or Coagulopathy
Arachnoid mater o Severe hypovolemia
• Soft impermeable translucent membrane that o Increased intracranial pressure (ICP)
loosely envelops the brain, o Severe aortic or mitral stenosis-
• Lies between the pia and the dura. It can cause abrupt decrease in blood pressure
• Between it and pia lies the subarachnoid space of the patient
which contains the cerebrospinal fluid. To manage this, preloading and IV crystalloids
Pia mater
20mL are given
• Innermost, thin delicate and highly vascular
membrane that contains the cord and the nerve • RELATIVE
roots. o Sepsis
• It is attached to the arachnoid and to the dura o Uncooperative patient
by the denticulate ligament. o Preexisting neurological deficit
o Severe spinal deformity (e.g. Scoliosis)
X. SPINAL / SUBARACHNOID BLOCK • CONTROVERSIAL
o Prior surgery at the site of injection
• INTRATHECAL injection of LA into the subarachnoid The site may be fibrotic
space.
o Complicated surgery
Subarachnoid space – where the CSF can be
found, hence, injecting of the agent here will o Prolonged operation
provide a more rapid onset. o Major blood loss
• SPINAL NERVES
In upper abdominal procedure, it is injected at the Complications
level of T4 (nipple area)
• Hypotension
Higher than this level is avoided because this is
where the cardioaccelatory fibers (T1-T4) are • Bradycardia
located, and therefore, can cause bradychardia. • Total Spinal Anesthesia
If injected higher than the spinal, it can cause loss • Neurological Complications: Cauda Equina Syndrome
of voice. • Post Dural Puncture Headache
If this happens during a procedure, the
anesthesiologists sedates the patient. • Infection
• LUMBAR PUNCTURE – done at the lumbar level only • Backache
o Below L1 (adults)– at the L3 and L4 level
o Below L3 (children)– at the L4 and L5 level
In children, there spinal cord ends at L3, hence,
above this level is avoided
Deposited on the sac to provide space for the RA
Blind procedure is sometimes done to avoid hitting
the cauda equina
Advantages
• Dense motor blockade
• No sacral sparing
• Fast onset
Figure 29: Caudal Block lifted from PPT Figure 31: Caudal Block lifted from PPT
Indications
• Anesthesia and analgesia below the umbilicus
• Obstetric analgesia
• Chronic pain problems
Contraindications
• Infection near the site of the needle insertion.
• Coagulopathy or anticoagulation therapy
• Congenital abnormalities of the lower spine or
meninges
Complications
• Intravascular or intraosseous injection.
• Dural puncture
• Perforation of the rectum
• Sepsis
• Urinary retention
• Hematoma
----------------------------END OF PART 1-----------------------------
XIII. APPENDIX